Article
Pharmacogenomics and Acquired Long QT Syndrome
1 Apr 2005
Abstract excerpt
During the past decade pharmaceutical companies have been faced with the withdrawal of some of their marketed drugs because of rare, yet lethal, postmarketing reports associated with ventricular arrhythmias. The implicated drugs include antiarrhythmics, but also non-cardiac drugs, such as histamine blockers, antipsychotics, and antibiotics. These undesired effects involve prolongation of the QT interval, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
